Neuca (LTS:0MJR) Cyclically Adjusted Revenue per Share: zł3,185.86 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0MJR Neuca SA LTS:0MJR
94 GF Score
Price zł760.00
GF Value zł911.33
! 4 Warning Signs
View Full Analysis

What is Neuca Cyclically Adjusted Revenue per Share?

Neuca LTS:0MJR 94 Cyclically Adjusted Revenue per Share is zł3,185.86 as of Mar. 2026. GuruFocus rates LTS:0MJR with a GF Score™ of 94/100 and a GF Value™ of zł911.33. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Neuca's adjusted revenue per share for the three months ended in Mar. 2026 was zł768.895. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is zł3,185.86 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Neuca's average Cyclically Adjusted Revenue Growth Rate was 7.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 8.20% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 12.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Neuca was 15.10% per year. The lowest was 8.20% per year. And the median was 13.60% per year.

As of today (2026-07-24), Neuca's current stock price is zł760.00. Neuca's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was zł3,185.86. Neuca's Cyclically Adjusted PS Ratio of today is 0.24.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Neuca was 0.58. The lowest was 0.17. And the median was 0.32.


Neuca  (LTS:0MJR) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Neuca's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=760.00/3185.86
=0.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Neuca was 0.58. The lowest was 0.17. And the median was 0.32.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Neuca Cyclically Adjusted Revenue per Share Related Terms


Neuca Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Neuca's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neuca Cyclically Adjusted Revenue per Share Chart

Neuca Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 762.99 2,505.18 1,948.41 2,231.81 2,530.67

Neuca Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,708.52 2,898.79 3,018.34 2,530.67 3,185.86

LTS:0MJR vs MCK, CAH, COR: Cyclically Adjusted Revenue per Share Comparison

For the Medical Distribution subindustry, Neuca's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neuca Cyclically Adjusted PS Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Neuca's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Neuca's Cyclically Adjusted PS Ratio falls into.


LTS:0MJR
94GF Score
Neuca SA LTS:0MJR
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Neuca Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Neuca's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=768.895/163.0700*163.0700
=768.895

Current CPI (Mar. 2026) = 163.0700.

Neuca Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 330.230 99.552 540.928
201609 335.526 99.064 552.312
201612 366.064 100.366 594.762
201703 399.892 101.018 645.536
201706 351.891 101.180 567.135
201709 358.144 101.343 576.285
201712 390.466 102.564 620.815
201803 415.477 102.564 660.580
201806 343.743 103.378 542.225
201809 372.456 103.378 587.517
201812 393.314 103.785 617.986
201903 431.195 104.274 674.332
201906 438.615 105.983 674.873
201909 434.559 105.983 668.632
201912 461.143 107.123 701.987
202003 602.569 109.076 900.847
202006 427.430 109.402 637.111
202009 512.323 109.320 764.218
202012 534.653 109.565 795.749
202103 500.088 112.658 723.868
202106 505.007 113.960 722.634
202109 548.996 115.588 774.516
202112 576.286 119.088 789.120
202203 613.479 125.031 800.125
202206 577.265 131.705 714.737
202209 624.505 135.531 751.400
202212 650.042 139.113 761.989
202303 671.878 145.950 750.688
202306 639.932 147.009 709.848
202309 657.864 146.113 734.211
202312 652.486 147.741 720.185
202403 697.118 149.044 762.724
202406 665.666 150.997 718.889
202409 697.906 153.439 741.711
202412 711.185 154.660 749.856
202503 735.392 157.021 763.723
202506 710.752 157.509 735.845
202509 762.085 158.000 786.539
202512 757.827 158.320 780.564
202603 768.895 163.070 768.895

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of zł3,185.86 mean?
Neuca (LTS:0MJR) has a Cyclically Adjusted Revenue per Share of zł3,185.86 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Neuca and its competitors.
Is Neuca's Cyclically Adjusted Revenue per Share too high?
Neuca's current Cyclically Adjusted Revenue per Share is zł3,185.86. Overall, Neuca has a GF Score™ of 94/100, reflecting its overall financial health beyond just this single metric.
How does Neuca's Cyclically Adjusted Revenue per Share compare to MCK and CAH?
Neuca's Cyclically Adjusted Revenue per Share of zł3,185.86 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Distribution company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Distribution industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Neuca and its competitors. Neuca's current Cyclically Adjusted Revenue per Share is zł3,185.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neuca stock overvalued right now?
Neuca (LTS:0MJR) has a current Cyclically Adjusted Revenue per Share of zł3,185.86. The stock's GF Value™ is zł911.33, compared to a current price of zł760.00 — trading 16.6% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is zł3,185.86. Neuca's overall GF Score™ is 94/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Neuca (LTS:0MJR), the current Cyclically Adjusted Revenue per Share is zł3,185.86 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Neuca (LTS:0MJR) Overvalued in 2026?

Based on GuruFocus' analysis, Neuca stock appears to be undervalued. The current stock price of zł760.00 is trading 16.6% below its estimated GF Value™ of zł911.33.

Key valuation signals for LTS:0MJR:

  • Cyclically Adjusted Revenue per Share: zł3,185.86
  • GF Value™: zł911.33 vs. price of zł760.00 (16.6% below fair value)
  • GF Score™: 94/100 with 4 warning signs

No single metric tells the full story. See the LTS:0MJR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Neuca Business Description

Other Exchanges NEU:Poland
Address ul. Forteczna 35‑37, Torun, POL, 87-100
Neuca SA is a wholesale distributor of pharmaceuticals in Poland. The company's segment includes Pharmacy wholesale; Manufacture of pharmaceuticals; Outpatient medical care clinics; Clinical trials and Insurance activities. It generates maximum revenue from the Pharmacy wholesale segment.
94GF Score

Get the complete analysis for LTS:0MJR

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł760.00
Price
zł911.33
GF Value